Applications for this meeting must be submitted by May 6, 2017. Please apply early, as some meetings become oversubscribed (full) before this deadline. If the meeting is oversubscribed, it will be stated here. Note: Applications for oversubscribed meetings will only be considered by the Conference Chair if more seats become available due to cancellations.
GRS Speaker Abstract Deadline: Although applications will be accepted until the date noted above, any applicants who wish to be considered for an oral presentation should submit their application by March 3, 2017. Please refer to the application instructions in the Meeting Description section below for more details (if available).
The Gordon Research Seminar on Tissue Repair and Regeneration is a unique forum for graduate students, post-docs, and other scientists with comparable levels of experience and education to present and exchange new data and cutting edge ideas.
The focus of this meeting is to share and present new research findings geared towards furthering our knowledge of basic mechanisms of tissue repair and
regeneration, to their clinical applications. Meeting will also encompass mentorship for graduates and postdocs from world renowned niche researchers in the field.
The meeting will feature approximately 10 talks and 2 poster sessions. All attendees are expected to actively participate in the GRS either by giving an oral presentation or presenting a poster. Therefore, all applications must include an abstract.
The Chairs will select speakers from abstracts submitted by March 3, 2017. Those applicants who are not chosen for talks and those who apply after the deadline to be considered for an oral presentation will be expected to present a poster. In order to participate, you must submit an application by the date indicated in the Application Deadline section above.
This GRS will be held in conjunction with the "Tissue Repair & Regeneration" Gordon Research Conference (GRC)
. Those interested in attending both meetings must submit an application for the GRC in addition to an application for the GRS. Refer to the associated GRC program page
for more information.
|2:00 pm - 5:00 pm||Arrival and Check-in|
|3:30 pm - 3:45 pm||Introductory Comments by GRC Site Staff / Welcome by the GRS Conference Chair|
|3:45 pm - 4:30 pm||Keynote Session: Perspectives in Tissue Repair and Regeneration|
|Discussion Leader: Alexander Hoachlandr-Hobby (Temple University, USA)|
|3:45 pm - 4:20 pm||Fiona Doetsch (Biozentrum, University of Basel, Switzerland)|
"Stem Cells and Their Niche in the Adult Brain"
|4:20 pm - 4:30 pm||Discussion|
|4:30 pm - 6:00 pm||Poster Session|
|7:30 pm - 9:30 pm||Stem Cells in Tissue Repair and Regeneration|
|Discussion Leader: Irene de Lazaro (The University of Manchester, United Kingdom)|
|7:30 pm - 7:45 pm||Hozana Castillo (Monash University, Australia)|
"Identification of the Cellular and Molecular Mechanisms of Zebrafish Spinal Cord Regeneration"
|7:45 pm - 7:55 pm||Discussion|
|7:55 pm - 8:10 pm||Syeda Nayab Abidi (University of Illinois at Urbana-Champaign, USA)|
"The Gene Brain Tumor Regulates Patterning and Regenerative Growth in Drosophila Imaginal Discs"
|8:10 pm - 8:15 pm||Discussion|
|8:15 pm - 8:30 pm||Young Chan Kang (University of New South Wales, Australia)|
"Identification of Novel Embryonic Vascular Stem-Like Cells and Their Role in Coronary Vascular Development and Repair"
|8:30 pm - 8:40 pm||Discussion|
|8:40 pm - 8:55 pm||Brian Kwee (Harvard University, USA)|
"T-Cell Phenotype Impacts Angiogenesis and Myogenesis In Vitro and In Vivo During Ischemic Injury"
|8:55 pm - 9:05 pm||Discussion|
|9:05 pm - 9:20 pm||Avani Yeola (University of New South Wales, Australia)|
"Generating Multipotent Stem Cells from Primary Human Adipocytes"
|9:20 pm - 9:30 pm||Discussion|
|7:30 am - 8:30 am||Breakfast|
|9:00 am - 11:00 am||Mechanisms and Targets in Tissue Repair and Regeneration|
|Discussion Leader: Richard Gieseck (National Institute of Allergy and Infectious Diseases, NIH, USA)|
|9:00 am - 9:15 am||Carlos Escudero (University of Toronto, Canada)|
"Hippo Effector TAZ as a Downstream Target of PDLIM7 in Regulation of Acute Skeletal Muscle Atrophy in Critical Illness"
|9:15 am - 9:25 am||Discussion|
|9:25 am - 9:40 am||Rana Herro (La Jolla Institute for Allergy and Immunology, USA)|
"The TNF Family Members LIGHT and TL1A Control Lung and Skin Fibrosis Associated with Scleroderma, IPF, Asthma and Atopic Dermatitis"
|9:40 am - 9:45 am||Discussion|
|9:45 am - 10:00 am||Rosario Sanchez-Gonzalez (Helmholtz Zentrum München, Germany)|
"Tissue Scaring - The Dark Side of Immune Response"
|10:00 am - 10:10 am||Discussion|
|10:10 am - 10:25 am||Guak Kim Tan (Shriners Hospitals for Children, USA)|
"Differentiated Tenocytes Revert to a Progenitor-Like State in Mice with Targeted Disruption of TGF-Beta Type II Receptor"
|10:25 am - 10:35 am||Discussion|
|10:35 am - 10:50 am||Nina Jordan (Institute of Cellular Medicine, Newcastle University, United Kingdom)|
"Preventing Endothelial-to-Mesenchymal Transition by Enhancing miR126-3p Expression"
|10:50 am - 11:00 am||Discussion|
|11:00 am - 12:30 pm||Poster Session|
|Coffee will be served in the poster area from 11:00 am - 11:30 am|
|1:30 pm - 2:30 pm||Mentorship Component: Career Panel|
|Understanding the challenges, developing essential and transferrable skills, and transitioning into independency.|
|Discussion Leader: Roshini Prakash (University of California, Los Angeles, USA)|
|1:30 pm - 2:30 pm||Panel Discussion|
|"The Hour to a Greater Career Achievement in Regeneration and Repair"|
- Fiona Doetsch (Biozentrum, University of Basel, Switzerland)
- Boris Hinz (University of Toronto, Canada)
|2:30 pm - 3:00 pm||Evaluation Period|
|Fill in GRS Evaluation Forms|
|3:00 pm||Seminar Concludes|
Funding for this conference was made possible (in part) by (1 R13AR71767-01) from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and all cofunding support provided by the National Institute on Child Health and Human Development (NICHD), and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.